Rocket Lab Corporation arrives at its August 6 earnings print carrying a striking three-way split: the CEO has been selling heavily at prices well above today's close, short interest has held near its highest level in months, and options traders are the most bullish they have been in weeks.
The insider story is the sharpest new signal since the last note. Founder and CEO Peter Beck sold more than 1.6 million shares across July 7–8, generating roughly $145 million in proceeds at prices ranging from $81 to $89. The stock now trades at $66.94 — meaning Beck was liquidating at a 25–33% premium to the current price. That is not a scheduled diversification trade that goes unnoticed; it is a concentrated cluster of sales by the company's most informed insider, at levels the stock has since failed to hold. Net insider activity over the past 90 days totals roughly $302 million in net sales, with no offsetting purchases reported.
Short interest has essentially stabilised at the elevated levels described in the prior note, though the build continues at a slower pace. At 9% of free float — up another 2% on the week and nearly 50% above where it started in June — bears have made their case and appear to be holding rather than aggressively adding. The lending market still offers no squeeze dynamics: availability is ample at roughly 324%, meaning more than three shares remain available to borrow for every one already lent, and cost to borrow has drifted lower to around 0.35%, near a multi-month low. Shorts face almost no friction. The ORTEX short score has edged up to 52.3 from 51 two weeks ago — moderate, not alarming — consistent with a positioning picture that is cautious but not extreme.
Options tell the opposing story. The put/call ratio has dropped to 0.68, nearly 1.7 standard deviations below its 20-day average of 0.71 — the most call-heavy reading in recent weeks, and far below the 52-week high of 0.85. That signals a tilt toward upside positioning, with call buyers dominant ahead of earnings. The divergence between steady short interest and a bullish options skew has been a feature of this setup for several weeks; it has not resolved, and if anything the call tilt has sharpened as the print approaches.
The valuation backdrop underscores how much faith the market is extending. EV/EBITDA runs above 770x on trailing numbers, price-to-book is near 20x, and the PE is deeply negative — entirely consistent with a pre-profitability aerospace name whose growth score ranks in the 74th percentile and whose EPS surprise history ranks in the 91st. Institutional holders are broadly constructive: BlackRock added nearly 5 million shares as of June 30, JP Morgan Asset Management added over 1 million, and State Street added 1.4 million. Baillie Gifford remains a sizeable holder at 3% of shares. The ownership picture leans long, even as the CEO reduces. Among peers, LUNR slipped 3.8% on the week while VOYG rose 5.2% — space-adjacent names are moving independently rather than as a group, which means the August 6 print will be judged on its own merits rather than sector tailwinds.
The next five trading sessions narrow to a single question: whether the Q2 results can offer enough forward visibility on Neutron and the Iridium integration to justify a stock that has already bounced 5% off its recent lows — with the CEO's July sale prices a clear reference point for where the prior consensus broke down.
See the live data behind this article on ORTEX.
Open RKLB on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
